Related Experiment Video

Updated: Jun 15, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Toward the optimization of stent-based treatment for coronary artery disease

Alfredo Romano1, Michael Rugaard Jensen, Jim McAlpine

  • 1Celgene International Sàrl, Route de Perreux 1, 2017 Boudry, Switzerland. aromano@celgene.com

Current Opinion in Drug Discovery & Development
|March 6, 2010
PubMed

Insights

Coronary artery disease treatments involve stents to open blocked arteries. Drug-eluting stents significantly reduce complications like thrombosis and restenosis, improving heart health.

Area of Science:

  • Cardiovascular Medicine
  • Biomaterials Science
  • Interventional Cardiology

Background:

  • Coronary artery disease (CAD) involves atherosclerotic plaque buildup, causing arterial stenosis and reduced heart oxygen supply.
  • Stent insertion is a key treatment to maintain vessel patency and prevent acute occlusion.
  • Stent thrombosis and in-stent restenosis are significant post-procedure complications.

Purpose of the Study:

  • To review advancements in stent-based therapies for coronary artery disease.
  • To highlight the evolution from bare-metal stents to drug-eluting stents.
  • To explore future directions in stent technology, including gene-eluting stents.

Main Methods:

  • Review of current literature on coronary stent technology and complications.
  • Analysis of the mechanisms and efficacy of drug-eluting stents (DES).
  • Discussion of antiplatelet therapy's role in mitigating stent thrombosis.

Main Results:

  • Adequate antiplatelet therapy has drastically reduced stent thrombosis rates.
  • Drug-eluting stents effectively address late in-stent restenosis by releasing bioactive agents.
  • Agents like sirolimus and tacrolimus are successfully incorporated into stents.

Conclusions:

  • Drug-eluting stents represent a major advancement in managing coronary artery disease.
  • Optimized antiplatelet regimens and DES have improved patient outcomes significantly.
  • Gene-eluting stents offer promising future avenues for enhanced stent-based therapies.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...